The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease is an age-related neurodegenerative disorder that is characterized by a progressive loss of memory and deterioration of higher cognitive functions. The brain of an individual with Alzheimer’s disease exhibits extracellular plaques of aggregated β-amyloid protein (Aβ), intracellular neurofibrillary tangles that contain hyperphosphorylated tau protein and a profound loss of basal forebrain cholinergic neurons that innervate the hippocampus and the neocortex. Aβ accumulation may trigger or contribute to the process of neurodegeneration. However, the mechanisms whereby Aβ induces basal forebrain cholinergic cell loss and cognitive impairment remain obscure. Physiologically relevant concentrations of Aβ-related peptides have acute, negative effects on multiple aspects of acetylcholine (ACh) synthesis and release, without inducing toxicity. These data suggest a neuromodulatory influence of the peptides on central cholinergic functions. Long-term exposure to micromolar Aβ induces cholinergic cell toxicity, possibly via hyperphosphorylation of tau protein. Conversely, activation of selected cholinergic receptors has been shown to alter the processing of the amyloid precursor protein as well as phosphorylation of tau protein. A direct interaction between Aβ and nicotinic ACh receptors has also been demonstrated. This review addresses the role of Aβ-related peptides in regulating the function and survival of central cholinergic neurons and the relevance of these effects to cholinergic deficits in Alzheimer’s disease. Understanding the functional interrelations between Aβ peptides, cholinergic neurons and tau phosphorylation will unravel the biologic events that precede neurodegeneration and may lead to the development of more effective pharmacotherapies for Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“Further proteolysis of the C-terminal fragment by γ-secretase yields the full-length Aβ1–40/42 peptide.(11,22,23,67,68) γ-Secretase activity resides in a multimeric protein complex that contains PS, which is considered to be a putative aspartyl protease,(69) along with at least 3 components (nicastrin, PEN-2 and APH-1…”
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 5×
“Reduced choline uptake, ACh release and loss of cholinergic neurons from the basal forebrain region further indicate a selective presynaptic cholinergic deficit in the hippocampus and neocortex of brains of individuals with AD.(48,50) Cholinergic neurons in the brain stem and striatum are either spared or affected onl…”
InfluentialPerry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Mattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Self-citationMechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
Senile dementia of the Alzheimer type
Terry, R. D., & Katzman, R. K. (1983) · Annals of Neurology · doi:10.1002/ana.410140502 · Cited by 829
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 779
γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., & Selkoe, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037392100 · Cited by 763
The Pathogenesis of Senile Plaques
DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 716
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
Vitamin E protects nerve cells from amyloid βprotein toxicity
Behl, C., Davis, J., Cole, G. M., & Schubert, D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90837-b · Cited by 581
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572
Buxbaum, J. D., Oishi, M., Chen, H. I., Pinkas-Kramarski, R., Jaffe, E. A., Gandy, S. E., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10075 · Cited by 559
Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520
Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease
Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250089017 · Cited by 514
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502
(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 499
Heber, S., Herms, J., Gajic, V., Hainfellner, J., Aguzzi, A., Rülicke, T., Kretzschmar, H., von Koch, C., Sisodia, S., Tremml, P., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07951.2000 · Cited by 494
Alpha-2 macroglobulin is genetically associated with Alzheimer disease
Blacker, D., Wilcox, M. A., Laird, N. M., Rodes, L., Horvath, S. M., Go, R. C. P., Perry, R., Watson, B., Bassett, S. S., McInnis, M. G., et al. (1998) · Nature Genetics · doi:10.1038/1243 · Cited by 486
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
Nagele, R. G., D’Andrea, M. R., Anderson, W. J., & Wang, H.-Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00460-2 · Cited by 455
BILLINGSLEY, M. L., & KINCAID, R. L. (1997) · Biochemical Journal · doi:10.1042/bj3230577 · Cited by 453
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons
Liu, Q.-S., Kawai, H., & Berg, D. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081553598 · Cited by 331
Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Self-citationβ-Amyloid1–42Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice
Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 290
Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia
Nordberg, A., Alafuzoff, I., & Winblad, B. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310115 · Cited by 270
Choline metabolism as a basis for the selective vulnerability of cholinergic neurons
Wurtman, R. J. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90351-8 · Cited by 246
Nicotinic receptor abnormalities in Alzheimer’s disease
Court, J., Martin-Ruiz, C., Piggott, M., Spurden, D., Griffiths, M., & Perry, E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01116-1 · Cited by 235
Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques
Giaccone, G., Tagliavini, F., Linoli, G., Bouras, C., Frigerio, L., Frangione, B., & Bugiani, O. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90169-9 · Cited by 231
Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death
Alvarez, A., Toro, R., Cáceres, A., & Maccioni, R. B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01279-x · Cited by 227
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 221
Neuronal α-Bungarotoxin Receptors Are α7 Subunit Homomers
Drisdel, R. C., & Green, W. N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00133.2000 · Cited by 215
Bondolfi, L., Calhoun, M., Ermini, F., Kuhn, H. G., Wiederhold, K.-H., Walker, L., Staufenbiel, M., & Jucker, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00515.2002 · Cited by 213
Dineley, K. T., Xia, X., Bui, D., Sweatt, J. D., & Zheng, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200164200 · Cited by 212
Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A., & Långström, B. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199505000-00006 · Cited by 212
Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M. R., Mark, R. J., Blanc, E. M., Roth, G. S., & Mattson, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6753 · Cited by 209
Shaw, K. T. Y., Utsuki, T., Rogers, J., Yu, Q.-S., Sambamurti, K., Brossi, A., Ge, Y.-W., Lahiri, D. K., & Greig, N. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131152998 · Cited by 205
Wong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196
Giovannini, M. G., Scali, C., Prosperi, C., Bellucci, A., Vannucchi, M. G., Rosi, S., Pepeu, G., & Casamenti, F. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0538 · Cited by 190
Buxbaum, J. D., Ruefli, A. A., Parker, C. A., Cypess, A. M., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4489 · Cited by 184
Pharmacology of Neuronal Nicotinic Acetylcholine Receptor Subtypes
Colquhoun, L. M., & Patrick, J. W. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60072-1 · Cited by 180
Kar, S., Issa, A. M., Seto, D., Auld, D. S., Collier, B., & Quirion, R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052179.x · Cited by 167
Self-citationGiovannelli, L., Casamenti, F., Scali, C., Bartolini, L., & Pepeu, G. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00610-h · Cited by 167
Alzheimer disease γ-secretase: a complex story of GxGD-type presenilin proteases
Haass, C., & Steiner, H. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02394-2 · Cited by 165
Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex
Mori, F., Lai, C.-C., Fusi, F., & Giacobini, E. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00012 · Cited by 157
Perini, G., Bianca, V. D., Politi, V., Valle, G. D., Prà, I. D., Rossi, F., & Armato, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011797 · Cited by 156
Nontoxic Amyloid β Peptide1-42 Suppresses Acetylcholine Synthesis
Hoshi, M. M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T., & Imahori, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2038 · Cited by 152
Teaktong, T., Graham, A., Court, J., Perry, R., Jaros, E., Johnson, M., Hall, R., & Perry, E. (2003) · Glia · doi:10.1002/glia.10132 · Cited by 151
?-amyloid binds to p75NTRand activates NF?B in human neuroblastoma cells
Kuner, P., Schubenel, R., & Hertel, C. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981215)54:6<798::aid-jnr7>3.0.co;2-t · Cited by 145
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles
Iqbal, K., Alonso, A. D. C., Gong, C., Khatoon, S., Pei, J. ‐., Wang, J. Z., & Grundke, I. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_15 · Cited by 143
Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited
Ladner, C. J., & Lee, J. M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00001 · Cited by 142 · cited 6×
“Cholinergic neurons in the brain stem and striatum are either spared or affected only in late stages of the disease.(45,47,48) Together with pharmacologic evidence of cholinergic involvement in the affected cognitive processes, these findings led to the development of a “cholinergic hypothesis” of AD.”
InfluentialNeurofibrillary tangles and tau phosphorylation
Brion, J., Anderton, B. H., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J., Pradier, L., Touchet, N., & Tremp, G. L. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670081 · Cited by 139
Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I., & Fisher, A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020877.x · Cited by 139
Kar, S., Seto, D., Gaudreau, P., & Quirion, R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01034.1996 · Cited by 134
Self-citationPedersen, W. A., Kloczewiak, M. A., & Blusztajn, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8068 · Cited by 134
Biology of Aβ Amyloid in Alzheimer's Disease
Wisniewski, T., Ghiso, J., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 134
Dysfunction of Cholinergic and Dopaminergic Neuronal Systems in β‐Amyloid Protein‐Infused Rats
Itoh, A., Nitta, A., Nadai, M., Kyoko, N., Hirose, M., Hasegawa, T., & NABESHIMA, T. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031113.x · Cited by 134
Cholinergic activity and amyloid precursor protein metabolism
Roberson, M. R., & Harrell, L. E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00016-7 · Cited by 127
Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 121
Koo, E. H., Sisodia, S. S., Cork, L. C., Unterbeck, A., Bayney, R. M., & Price, D. L. (1990) · Neuron · doi:10.1016/0896-6273(90)90446-m · Cited by 119
Wallace, W., Ahlers, S. T., Gotlib, J. R., Bragin, V., Sugar, J., Gluck, R., SHEA, P. A., Davis, K. L., & Haroutunian, V. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8712 · Cited by 118
Rodríguez‐Puertas, R., Pascual, J., Vilaró, M. T., & Pazos, Á. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199708)26:4<341::aid-syn2>3.0.co;2-6 · Cited by 112
Lin, L., Georgievska, B., Mattsson, A., & Ole Isacson, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12108 · Cited by 110
Genotype and phenotype in Alzheimer's disease
Holmes, C. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.131 · Cited by 104
Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor.
Joslin, G., Krause, J. E., Hershey, A. D., Adams, S., Fallon, R. J., & Perlmutter, D. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54721-9 · Cited by 103
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103
Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 93
Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86
Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid
Pike, C. J., & Cotman, C. W. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90331-9 · Cited by 86
Abe, E., Casamenti, F., Giovannelli, L., Scali, C., & Pepeu, G. (1994) · Brain Research · doi:10.1016/0006-8993(94)90193-7 · Cited by 85
Hellström‐Lindahl, E., Moore, H., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740777.x · Cited by 81
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients
Mulugeta, E., Karlsson, E., Islam, A., Kalaria, R. N., Mangat, H. S., Winblad, B. G., & Adem, A. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03542-4 · Cited by 80
Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
Lahiri, D. K., Farlow, M. R., Hintz, N., Utsuki, T., & Greig, N. H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00309.x · Cited by 77
Disruption of the cytoskeleton in Alzheimer's disease
Lee, V. M. ‐. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80073-5 · Cited by 76
Hellström‐Lindahl, E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00028-5 · Cited by 76
Cellular Mechanisms for Amyloid β-Protein Activation of Rat Cholinergic Basal Forebrain Neurons
Jhamandas, J. H., Cho, C., Jassar, B. S., Harris, K. H., MacTavish, D., & Easaw, J. C. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.3.1312 · Cited by 70
Lee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67
Warpman, U., Alafuzoff, I., & Nordberg, A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90103-r · Cited by 67
Harkany, T., Lengyel, Z., Soós, K., Penke, B., Luiten, P. G. M., & Gulya, K. (1995) · Brain Research · doi:10.1016/0006-8993(95)00823-9 · Cited by 66
The pharmacology of amyloid precursor protein processing
Racchi, M., & Govoni, S. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00158-4 · Cited by 63
Kim, S., Kim, Y. K., Jeong, S., Haass, C., Kim, Y.-H., & Suh, Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.430 · Cited by 63
Racchi, M., Sironi, M., Caprera, A., König, G., & Govoni, S. M. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000878 · Cited by 60
Gau, J., Steinhilb, M. L., Kao, T.-C., D’Amato, C. J., Gaut, J. R., Frey, K. A., & Turner, R. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64893-6 · Cited by 56
Wang, H.-Y., Wild, K. D., Shank, R. P., & Lee, D. H. S. (1999) · Neuropeptides · doi:10.1054/npep.1999.0024 · Cited by 53
Lahiri, D. K., Utsuki, T., Chen, D., Farlow, M. R., Shoaib, M., Ingram, D. K., & Greig, N. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04178.x · Cited by 52
Vaucher, E., Aumont, N., Pearson, D., Rowe, W. B., Poirier, J., & Kar, S. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00120-x · Cited by 49
Self-citationLe, W., Xie, W., Kong, R., & Appel, S. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69030978.x · Cited by 48
Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration.
Iverfeldt, K., Walaas, S. I., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4146 · Cited by 43
Effect of Ginseng Saponins on β-Amyloid-Suppressed Acetylcholine Release from Rat Hippocampal Slices
Lee, T.-F., Shiao, Y.-J., Chen, C., & WANG, L. C. H. (2001) · Planta Medica · doi:10.1055/s-2001-17366 · Cited by 42
Shea, T. B., Prabhakar, S., & Ekinci, F. J. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<759::aid-jnr10>3.0.co;2-n · Cited by 40
Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum
Pittel, Z., Heldman, E., Barg, J., Haring, R., & Fisher, A. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01031-1 · Cited by 40
Beta-amyloid induced increase in choline flux across PC12 cell membranes
Allen, D. D., Galdzicki, Z., Brining, S. K., Fukuyama, R., Rapoport, S. I., & Smith, Q. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00671-x · Cited by 38
Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37
Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells
Olesen, O. F., Dagø, L., & Mikkelsen, J. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00096-5 · Cited by 36
Dobránsky, T., Brewer, D., Lajoie, G., & Rylett, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212080200 · Cited by 34
Secreted β-APP stimulates MAP kinase and phosphorylation of tau in neurons
Greenberg, S. M., & Kosik, K. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00172-w · Cited by 28
β-Amyloid and Cholinergic Neurons
Doležal, V., & Kašparová, J. (2003) · Neurochemical Research · doi:10.1023/a:1022865121743 · Cited by 27
Human Amylin Actions on Rat Cholinergic Basal Forebrain Neurons: Antagonism of Beta-Amyloid Effects
Jhamandas, J. H., Harris, K. H., Cho, C., Fu, W., & MacTavish, D. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01138.2002 · Cited by 26
Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells
Pedersen, W. A., & Blusztajn, J. K. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00913-0 · Cited by 25
Lack of association between α2-macroglobulin polymorphisms and Alzheimer's disease
Wang, X., Luedecking‐Zimmer, E., Minster, R. L., Ganguli, M., DeKosky, S. T., & Kamboh, M. I. (2001) · Human Genetics · doi:10.1007/s004390000445 · Cited by 25
Neuropathology in the Down's syndrome brain
Tanzi, R. E. (1996) · Nature Medicine · doi:10.1038/nm0196-31 · Cited by 24
Wecker, L. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08269.x · Cited by 23
Huang, H., Ou, H., & Hsieh, S. (2000) · Neurochemical Research · doi:10.1023/a:1007592007956 · Cited by 21
Satoh, Y., Hirakura, Y., Shibayama, S., Hirashima, N., Suzuki, T., & Kirino, Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01665-2 · Cited by 21
Melo, J. B., Agostinho, P. M., & Oliveira, C. R. (2002) · Amyloid · doi:10.3109/13506120209114097 · Cited by 18
Kar, S. (2002) · Drug Development Research · doi:10.1002/ddr.10080 · Cited by 14
Self-citation(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
Craig, L. A., Hong, N. S., & McDonald, R. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.001 · Cited by 486
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Kaur, D., Sharma, V., & Deshmukh, R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 484
Muscarinic acetylcholine receptors as CNS drug targets
Langmead, C. J., Watson, J., & Reavill, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 419
Park, J., Lee, B. K., Jeong, G. S., Hyun, J. K., Lee, C. J., & Lee, S.-H. (2015) · Lab on a Chip · doi:10.1039/c4lc00962b · Cited by 350
Metadata
- Authors
- Kar, S., Slowikowski, S. P. M., Westaway, D., & Mount, H. T. J.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2004-11
- Volume
- 29
- Issue
- 6
- Pages
- 427-441
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W4413980012
- Cited by
- 364
- References
- 142
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.